Quantum-Si Incorporated has attracted investments from a prominent roster of institutional asset managers, venture capital funds, and specialized life science investors. Key institutional stakeholders holding significant blocks of common stock include major global financial entities such as The Vanguard Group, ARK Investment Management, Geode Capital Management, and Millennium Management, alongside early-stage backers and visionary founder-backed investments that provided the initial capital foundation to scale its semiconductor proteomics technology.